[HTML][HTML] Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

…, JL Halperin, GJ Hankey, JP Piccini… - … England Journal of …, 2011 - Mass Medical Soc
Background The use of warfarin reduces the rate of ischemic stroke in patients with atrial
fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor …

Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA …

…, PR Kowey, GV Naccarelli, JA Reiffel, JP Piccini… - Jama, 2019 - jamanetwork.com
Importance Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF),
but its effects on long-term mortality and stroke risk are uncertain. Objective To determine …

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

KAA Fox, JP Piccini, D Wojdyla, RC Becker… - European heart …, 2011 - academic.oup.com
Aims Patients with non-valvular atrial fibrillation (AF) and renal insufficiency are at increased
risk for ischaemic stroke and bleeding during anticoagulation. Rivaroxaban, an oral, direct …

Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries: 1993–2007

JP Piccini, BG Hammill, MF Sinner… - … Quality and Outcomes, 2012 - Am Heart Assoc
Background— Atrial fibrillation (AF) is a common and costly problem among older persons.
The frequency of AF increases with age, but representative national data about incidence …

Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration

…, C Martinez, L Neubeck, J Orchard, JP Piccini… - Circulation, 2017 - Am Heart Assoc
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first diagnosed
at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent …

Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET …

JP Piccini, SR Stevens, YC Chang, DE Singer… - Circulation, 2013 - Am Heart Assoc
Background— We sought to define the factors associated with the occurrence of stroke and
systemic embolism in a large, international atrial fibrillation (AF) trial. Methods and Results— …

Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial

DL Packer, JP Piccini, KH Monahan, HR Al-Khalidi… - Circulation, 2021 - Am Heart Assoc
Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …

Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial

DB Mark, KJ Anstrom, S Sheng, JP Piccini, KN Baloch… - Jama, 2019 - jamanetwork.com
Importance Catheter ablation is more effective than drug therapy in restoring sinus rhythm in
patients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) …

Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry

…, J Reiffel, DE Singer, ED Peterson, JP Piccini… - Journal of the American …, 2016 - jacc.org
Background : Although non-vitamin K antagonist oral anticoagulants (NOACs) do not require
frequent laboratory monitoring, each compound requires dose adjustments on the basis of …

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor …

JL Halperin, GJ Hankey, DM Wojdyla, JP Piccini… - Circulation, 2014 - Am Heart Assoc
Background— Nonvalvular atrial fibrillation is common in elderly patients, who face an
elevated risk of stroke but difficulty sustaining warfarin treatment. The oral factor Xa inhibitor …